Inventor · disambiguated record
Rong Zhang
Also filed as: ZHANG RONG · Zhang rong-lin
44 granted patents·23 pending applications·124 citations·filing 1994–2025
97Inventor score
Files withGEN ELECTRIC12ABBOTT LAB4BEIJING DCTY BIOTECH CO LTD4NANO TARGETING & THERAPY BIOPHARMA INC4HANGZHOU CONVERD CO LTD3
Top patents by PatentIndex Score
67 records- 0193US7763731B2Anti-viral compoundsABBOTT LAB·Filed 2006·Granted Jul 27, 2010·37 cites·8 claims
- 0292US11180443B2Preparation method for m-diamide compoundsCAC NANTONG CHEMICAL CO LTD·Filed 2020·Granted Nov 23, 2021·4 cites·20 claims
- 0390US10981861B1Bromination method for m-diamide compoundsCHANG SHA JIA QIAO BIOTECH CO LTD·Filed 2020·Granted Apr 20, 2021·3 cites·19 claims
- 0489US7910595B2Anti-viral compoundsABBOTT LAB·Filed 2006·Granted Mar 22, 2011·18 cites·20 claims
- 0588US10159760B2HER2 bindersGEN ELECTRIC·Filed 2016·Granted Dec 25, 2018·4 cites·6 claims
- 0687US10844005B1Method for preparing an N-cyclopropylmethyl aniline compoundCHANG SHA JIA QIAO BIOTECH CO LTD·Filed 2020·Granted Nov 24, 2020·2 cites·20 claims
- 0786US7902332B2Fluorine-labeled compoundsGEN ELECTRIC·Filed 2006·Granted Mar 8, 2011·11 cites·18 claims
- 0885US8658129B2Agents and methods for the imaging of myelin basic proteinZHANG RONG·Filed 2011·Granted Feb 25, 2014·4 cites·18 claims
- 0985US8124725B2PDGF-Rβ bindersMARINO MICHAEL ERNEST·Filed 2008·Granted Feb 28, 2012·8 cites·26 claims
- 1082US8362281B2Intermediates for hydroxylated contrast enhancement agentsGEN ELECTRIC·Filed 2010·Granted Jan 29, 2013·4 cites·19 claims
- 1181US7915411B2Anti-viral compoundsABBOTT LAB·Filed 2006·Granted Mar 29, 2011·3 cites·3 claims
- 1280US10894097B2HER2 bindersGEN ELECTRIC·Filed 2018·Granted Jan 19, 2021·1 cites·10 claims
- 1380US2024139352A1Her2 bindersGEN ELECTRIC·Filed 2023·Application pending·0 cites
- 1475US8236950B2Anti-viral compoundsBETEBENNER DAVID A·Filed 2007·Granted Aug 7, 2012·3 cites·19 claims
- 1574US11633507B2HER2 bindersGEN ELECTRIC·Filed 2020·Granted Apr 25, 2023·0 cites·8 claims
- 1673US12274688B2Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain metastasesNANO TARGETING & THERAPY BIOPHARMA INC·Filed 2022·Granted Apr 15, 2025·0 cites·10 claims
- 1773US9730940B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·3 cites·9 claims
- 1872US9040019B2Methods of detecting myelin basic proteinGEN ELECTRIC·Filed 2012·Granted May 26, 2015·2 cites·23 claims
- 1971US6710200B2Cyanohydrin ethers and esters as high-sensitivity enzyme substratesUNIV CALIFORNIA·Filed 2003·Granted Mar 23, 2004·5 cites·23 claims
- 2070US11691943B2Preparation method of 4-(heptafluoro-2-propyl)-2-trifluoromethylaniline and application thereofJIANGXI TIANYU CHEMICAL CO LTD·Filed 2022·Granted Jul 4, 2023·0 cites·10 claims
- 2169US8487080B2Fluorine-labeled compoundsPADILLA DE JESUS OMAYRA LIZ·Filed 2011·Granted Jul 16, 2013·1 cites·20 claims
- 2268US7772363B2Two helix bindersGEN ELECTRIC·Filed 2008·Granted Aug 10, 2010·0 cites·7 claims
- 2367US8734580B2Carbonyl propyl sulfuryl anthrapyridone sulfonic acid compounds and their preparation methods and applicationsUNIV DALIAN TECH·Filed 2013·Granted May 27, 2014·1 cites·17 claims
- 2466US12016958B2Method for delivering an agent to posterior segment of an eye and uses thereofNANO TARGETING & THERAPY BIOPHARMA INC·Filed 2022·Granted Jun 25, 2024·0 cites·16 claims
- 2563US2025020639A1Ultra-bright nanoparticle fluorescent dye complexesCYTEK BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2662US12329826B2Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereofHANGZHOU CONVERD CO LTD·Filed 2019·Granted Jun 17, 2025·0 cites·17 claims
- 2762US2025241886A1Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain metastasesNANO TARGETING & THERAPY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2861US11752133B2Use of bromophenol-pyrazoline compounds in the treatment of porcine coronavirus diseasesSHANDONG LINGHAI BIOTECHNOLOGY CO LTD·Filed 2021·Granted Sep 12, 2023·0 cites·3 claims
- 2960US6528675B1Cyanohydrin ethers and esters as high-sensitivity enzyme substratesUNIV CALIFORNIA·Filed 2001·Granted Mar 4, 2003·2 cites·20 claims
- 3060US2024124553A1Compositions and methods for inhibition of alphavirus infectionWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 3159US7981691B2Two helix bindersGEN ELECTRIC·Filed 2008·Granted Jul 19, 2011·0 cites·7 claims
- 3259US7977118B2Two helix bindersGEN ELECTRIC·Filed 2008·Granted Jul 12, 2011·0 cites·7 claims
- 3359US2021015757A1Drug delivery by pore-modified mesoporous silica nanoparticlesCHAN HARDY WAI HONG·Filed 2020·Application pending·0 cites
- 3458US12496355B2Method for treating a cancer and/or cancer metastasisNANO TARGETING & THERAPY BIOPHARMA INC·Filed 2022·Granted Dec 16, 2025·0 cites·16 claims
- 3558US7989216B2Two helix bindersGEN ELECTRIC·Filed 2008·Granted Aug 2, 2011·0 cites·8 claims
- 3656US2023265396A1Isolated recombinant oncolytic poxvirus capable of being regulated and controlled by microrna and use thereofHANGZHOU CONVERD CO LTD·Filed 2021·Application pending·0 cites
- 3754US11407710B2Method for preparing an N-cyclopropylmethyl aniline compoundJIANGXI UNIVATE NEW MAT CO LTD·Filed 2021·Granted Aug 9, 2022·0 cites·30 claims
- 3852US12448415B2Compositions and methods for inhibition of alphavirus infectionWASHINGTON UNIVERSITY ST LOUIS·Filed 2019·Granted Oct 21, 2025·0 cites·20 claims
- 3952US9011589B2Magenta dyes and their preparation methods and applicationsUNIV DALIAN TECH·Filed 2014·Granted Apr 21, 2015·0 cites·20 claims
- 4052US2012165650A1Her2 bindersSYUD FAISAL AHMED·Filed 2010·Application pending·0 cites
- 4152US2024131086A1Use of clostridium ghonii combined with tumor angiogenesis inhibitorSHIHUIDA PHARMACEUTICAL GROUP JILIN CO LTD·Filed 2022·Application pending·0 cites
- 4249US2024115627A1Use of clostridium ghonii spore combined with pembrolizumabSHANDONG XINCHUANG BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 4348US8834839B2Labeled molecular imaging agents, methods of making and methods of useSCHAFFER PAUL·Filed 2009·Granted Sep 16, 2014·0 cites·5 claims
- 4447US2004087577A1Anti-infective agentsPRATT JOHN K·Filed 2003·Application pending·0 cites
- 4546US2004097492A1Anti-infective agentsPRATT JOHN K·Filed 2002·Application pending·0 cites
- 4643US8591641B2Weather-resistant dye and use thereofPENG XIAOJUN·Filed 2009·Granted Nov 26, 2013·0 cites·8 claims
- 4743US2020289591A1Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition, and Use Thereof in Treatment of Tumors and/or CancerHANGZHOU CONVERD CO LTD·Filed 2018·Application pending·0 cites
- 4842US2010310456A1Imaging of myelin basic proteinGEN ELECTRIC·Filed 2010·Application pending·0 cites
- 4942US2005075331A1Anti-infective agentsFiled 2003·Application pending·0 cites
- 5041US9938281B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Apr 10, 2018·0 cites·18 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rong Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →